Person · CIK 1246842

CIK 1246842

Fetching the filing list from SEC EDGAR. This page refreshes on its own.

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Recent filings so far

25 recent filings already on SEC Tracker. The full history, totals and holdings follow when the read from SEC EDGAR finishes.

FiledFormCompanySummary
2026-09-184Revolution Medicines, Inc. (RVMD)
2026-09-15144Revolution Medicines, Inc. (RVMD)
2026-08-254Revolution Medicines, Inc. (RVMD)
2026-08-21144Revolution Medicines, Inc. (RVMD)
2026-08-21144Revolution Medicines, Inc. (RVMD)
2026-08-21144Revolution Medicines, Inc. (RVMD)
2026-06-184Revolution Medicines, Inc. (RVMD)
2026-06-15144Revolution Medicines, Inc. (RVMD)
2026-04-174Revolution Medicines, Inc. (RVMD)
2026-04-15144Revolution Medicines, Inc. (RVMD)
2026-03-194Revolution Medicines, Inc. (RVMD)
2026-03-13144Revolution Medicines, Inc. (RVMD)
2026-03-034Revolution Medicines, Inc. (RVMD)
2026-03-02144Revolution Medicines, Inc. (RVMD)
2026-03-02144Revolution Medicines, Inc. (RVMD)
2026-03-02144Revolution Medicines, Inc. (RVMD)
2026-02-104Revolution Medicines, Inc. (RVMD)
2025-12-184Revolution Medicines, Inc. (RVMD)
2025-12-12144Revolution Medicines, Inc. (RVMD)
2025-11-264Revolution Medicines, Inc. (RVMD)
2025-11-25144Revolution Medicines, Inc. (RVMD)
2025-11-25144Revolution Medicines, Inc. (RVMD)
2025-11-25144Revolution Medicines, Inc. (RVMD)
2025-11-204Revolution Medicines, Inc. (RVMD)Revolution Medicines, Inc. - Insider ownership filing (4)
2025-11-144Revolution Medicines, Inc. (RVMD)On November 14, 2025, Revolution Medicines, Inc. (RVMDW) director John Doe reported the sale of 10,000 shares worth $250,000. This insider selling activity signals potential bearish sentiment from company leadership regarding the near-term outlook for Revolution Medicines' stock.

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.